These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 5428114)
21. [Effect of nifedipine on the clinical manifestations of ischemic heart disease occurring with stable stenocardia and the hemodynamic indices]. Ostapiuk FE; Dobrotvorskaia TE; Al'khavazha Kh Kardiologiia; 1986 Aug; 26(8):82-3. PubMed ID: 3761855 [No Abstract] [Full Text] [Related]
22. [Use of a two-component analysis of myocardial contractility during rehabilitation of patients with ischemic heart disease]. Ponomarev IuA; Kuzmina MM; Bykov II; Ryzhenkov VN; Fadina ZM; Vostrikov VE Sov Med; 1991; (6):51-3. PubMed ID: 1887306 [No Abstract] [Full Text] [Related]
23. [Changes in the indicators of intracardiac hemodynamics in patients with post-infarction cardiosclerosis under the action of verapamil]. Komissarov VA Kardiologiia; 1990 Aug; 30(8):60-3. PubMed ID: 2147729 [TBL] [Abstract][Full Text] [Related]
24. [Clinico-experimental characteristic of the new cardiac glycoside homphotin]. Gatsura VV; Stupnitskiĭ AA Kardiologiia; 1968 Sep; 8(9):106-10. PubMed ID: 5728493 [No Abstract] [Full Text] [Related]
25. [Use of metabolically active agents in ischemic heart disease patients]. Denisiuk VI Vrach Delo; 1986 Aug; (8):11-4. PubMed ID: 3776144 [No Abstract] [Full Text] [Related]
26. [Treatment of patients with ischemic heart diseases using senzit]. Zamotaev IP; Venediktova MG; Zakharova GIu Klin Med (Mosk); 1988 Aug; 66(8):68-71. PubMed ID: 3193737 [No Abstract] [Full Text] [Related]
27. [Hemodynamic and clinical studies of the coronary therapeutic agent oxyfedrin]. Krosch H; Rikirsch P; Schäbitz J; Teichmann W Z Arztl Fortbild (Jena); 1972 Jun; 66(11):557-62. PubMed ID: 5072115 [No Abstract] [Full Text] [Related]
28. [Mechanisms of the anti-anginal effect of obzidan]. Furkalo NK; Zaĭtseva VI Kardiologiia; 1984 Jun; 24(6):73-6. PubMed ID: 6748496 [TBL] [Abstract][Full Text] [Related]
29. [Dynamics of the clinical biochemical indices in postinfarct cardiosclerosis with a stenocardiac syndrome under anabolic steroid therapy]. Khimenko LP Klin Med (Mosk); 1981 Jul; 59(7):42-5. PubMed ID: 7278098 [No Abstract] [Full Text] [Related]
30. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients]. Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152 [TBL] [Abstract][Full Text] [Related]
31. [Effects on the hemodynamics and myocardial contractility of 2 beta blockader agents: propranolol and proctolol]. Sanguinetti M; Picchio FM; Maresta A; Branzi A; Baccarani G; Binetti G G Ital Cardiol; 1972; 2(5):710-9. PubMed ID: 4404053 [No Abstract] [Full Text] [Related]
33. Trial of two beta blockade drugs, Ciba 39089 and ICI 50172, in angina pectoris. Nellen M S Afr Med J; 1969 Dec; ():Suppl:15-7. PubMed ID: 4392020 [No Abstract] [Full Text] [Related]
34. [On Myocardon therapy of patients with coronary sclerosis and cardiosclerosis]. Kreisel D Ther Ggw; 1965 Aug; 104(8):1072-88. PubMed ID: 5845747 [No Abstract] [Full Text] [Related]
35. [The effect of nitroglycerin and of a new beta-blocking agent (metroprlolo) on exercise tolerance in ischemic patients]. Mosti GB; Tomei G; Giusti C; Galetta F; Rossi M; Santoro G Boll Soc Ital Cardiol; 1978; 23(3):589-96. PubMed ID: 111693 [No Abstract] [Full Text] [Related]
36. [Use of a static exercise test for evaluating anti-angina effects of drugs in patients with ischemic heart disease at a polyclinic]. Gel'fgat EB; Muradova SA; Iagizarova NM; Abdullaeva IA Kardiologiia; 1988 Oct; 28(10):47-51. PubMed ID: 3147339 [TBL] [Abstract][Full Text] [Related]